F90. RARE VARIANTS, RISK OF DISEASE, AND SENSITIVITY TO PSYCHOTROPICS SUGGESTS PERSONALIZED PHARMACOGENOMICS: TIME TO ADVANCE THE ROLE OF MOLECULAR PSYCHIATRY AT THE BEDSIDE